Pfizer to boost COVID-19 pill production with French deal – The Peninsula Qatar

Pfizer to boost COVID-19 pill production with French deal – The Peninsula Qatar

PARIS: Pfizer will add a production facility for its antiviral COVID-19 pill in France as part of a plan to invest 520 million euros ($594 million) in the country over the next five years, the U.S. drugmaker said on Monday.

The decision is part of Pfizer's strategy to boost global production of the pill, paxlovid, which was found to be nearly 90% effective in preventing hospitalizations and deaths in patients at high risk of severe illness, according to clinical trial data.